355 related articles for article (PubMed ID: 28392225)
1. Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal's medium.
Kumar A; Sachu A; Mohan K; Vinod V; Dinesh K; Karim S
Rev Iberoam Micol; 2017; 34(2):109-111. PubMed ID: 28392225
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of Candida dubliniensis on chrom agar and Pal's agar.
Raut SH; Varaiya A
Indian J Med Microbiol; 2009; 27(1):55-8. PubMed ID: 19172062
[TBL] [Abstract][Full Text] [Related]
3. Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis.
Sahand IH; Moragues MD; Eraso E; Villar-Vidal M; Quindós G; Pontón J
J Clin Microbiol; 2005 Nov; 43(11):5768-70. PubMed ID: 16272515
[TBL] [Abstract][Full Text] [Related]
4. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Candida dubliniensis from Candida albicans on Pal's agar.
Al Mosaid A; Sullivan DJ; Coleman DC
J Clin Microbiol; 2003 Oct; 41(10):4787-9. PubMed ID: 14532221
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel.
Ben-Ami R; Berman J; Novikov A; Bash E; Shachor-Meyouhas Y; Zakin S; Maor Y; Tarabia J; Schechner V; Adler A; Finn T
Emerg Infect Dis; 2017 Feb; 23(1):195-203. PubMed ID: 28098529
[TBL] [Abstract][Full Text] [Related]
7. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.
Ramos LS; Figueiredo-Carvalho MH; Barbedo LS; Ziccardi M; Chaves AL; Zancopé-Oliveira RM; Pinto MR; Sgarbi DB; Dornelas-Ribeiro M; Branquinha MH; Santos AL
J Antimicrob Chemother; 2015 Jan; 70(1):111-5. PubMed ID: 25134720
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of different methods for the identification of Candida species isolated from clinical specimens].
Cetinkaya Z; Altindiş M; Aktepe OC; Karabiçak N
Mikrobiyol Bul; 2003 Oct; 37(4):269-76. PubMed ID: 14748264
[TBL] [Abstract][Full Text] [Related]
9. Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?
Mizusawa M; Miller H; Green R; Lee R; Durante M; Perkins R; Hewitt C; Simner PJ; Carroll KC; Hayden RT; Zhang SX
J Clin Microbiol; 2017 Feb; 55(2):638-640. PubMed ID: 27881617
[No Abstract] [Full Text] [Related]
10. Single-tube classical PCR for Candida auris and Candida haemulonii identification.
Theill L; Dudiuk C; Morales-Lopez S; Berrio I; Rodríguez JY; Marin A; Gamarra S; Garcia-Effron G
Rev Iberoam Micol; 2018; 35(2):110-112. PubMed ID: 29685376
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis.
Eraso E; Sahand IH; Villar-Vidal M; Marcos C; Dolores Moragues M; Madariaga L; Pontón J; Quindós G
Med Mycol; 2006 Nov; 44(7):611-5. PubMed ID: 17071554
[TBL] [Abstract][Full Text] [Related]
12. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans.
Khan ZU; Ahmad S; Mokaddas E; Chandy R
J Clin Microbiol; 2004 Oct; 42(10):4796-8. PubMed ID: 15472343
[TBL] [Abstract][Full Text] [Related]
13. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts.
Cendejas-Bueno E; Kolecka A; Alastruey-Izquierdo A; Theelen B; Groenewald M; Kostrzewa M; Cuenca-Estrella M; Gómez-López A; Boekhout T
J Clin Microbiol; 2012 Nov; 50(11):3641-51. PubMed ID: 22952266
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples.
Mulet Bayona JV; Salvador García C; Tormo Palop N; Gimeno Cardona C
Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115168. PubMed ID: 32927410
[TBL] [Abstract][Full Text] [Related]
15. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
Khan Z; Ahmad S; Al-Sweih N; Joseph L; Alfouzan W; Asadzadeh M
PLoS One; 2018; 13(4):e0195743. PubMed ID: 29630658
[TBL] [Abstract][Full Text] [Related]
16. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.
Odds FC; Bernaerts R
J Clin Microbiol; 1994 Aug; 32(8):1923-9. PubMed ID: 7989544
[TBL] [Abstract][Full Text] [Related]
17. Different classes of hydrolytic enzymes produced by multidrug-resistant yeasts comprising the Candida haemulonii complex.
Ramos LS; Branquinha MH; Santos AL
Med Mycol; 2017 Feb; 55(2):228-232. PubMed ID: 27555559
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the potential virulence of Candida haemulonii species complex and Candida auris isolates in Caenorhabditis elegans as an in vivo model and correlation to their biofilm production capacity.
Lima SL; Rossato L; Salles de Azevedo Melo A
Microb Pathog; 2020 Nov; 148():104461. PubMed ID: 32835773
[TBL] [Abstract][Full Text] [Related]
19. Superficial candidosis by Candida duobushaemulonii: An emerging microorganism.
Frías-De-León MG; Martínez-Herrera E; Acosta-Altamirano G; Arenas R; Rodríguez-Cerdeira C
Infect Genet Evol; 2019 Nov; 75():103960. PubMed ID: 31325612
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness and efficacy of CHROMagar Candida medium in clinical specimens.
Momani OM
East Mediterr Health J; 2000; 6(5-6):968-78. PubMed ID: 12197356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
